HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronika-Viktorija Borutinskaite Selected Research

N1- (2- aminophenyl)- N8- phenyloctanediamide

1/2012Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.
11/2006The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronika-Viktorija Borutinskaite Research Topics

Disease

3Leukemia
12/2012 - 11/2006
3Neoplasms (Cancer)
12/2012 - 01/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2012

Drug/Important Bio-Agent (IBA)

3Histone Deacetylase InhibitorsIBA
12/2012 - 11/2006
2pyrimidin-2-one beta-ribofuranosideIBA
12/2012 - 01/2012
2N1- (2- aminophenyl)- N8- phenyloctanediamideIBA
01/2012 - 11/2006
1RG108IBA
12/2012
1NucleosidesIBA
12/2012
1Butyrates (Butyrate)IBA
01/2012
1Cadherins (E-Cadherin)IBA
01/2012
1CytidineIBA
01/2012

Therapy/Procedure

3Therapeutics
12/2012 - 01/2012